Hallena Strotman
Merck & Co.
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Hallena Strotman.
Chemcatchem | 2012
Matthew D. Truppo; Hallena Strotman; Gregory Hughes
Considerable effort has been spent to develop efficient, catalytic methods for the preparation of enantiomerically pure chiral amines as pharmaceutical building blocks. Biocatalytic approaches have largely relied on kinetic resolution of racemic amines using lipases. In some instances, in situ racemization of the unreactive enantiomer has permitted dynamic kinetic resolutions to be performed. Racemic amines can also be deracemized using an amine oxidase combined with a nonselective reducing agent. The emergence of transaminases, which catalyze the direct amination of prochiral ketones, has provided an attractive alternative option for the synthesis chiral amines. Tufvesson et al. have published an excellent review of the process challenges encountered when using transaminases for the synthesis of chiral amines. We previously reported on the creation of an active and stable R-selective amine transaminase for the synthesis of sitagliptin by using a combination of modeling and directed evolution (Scheme 1). A limitation of the protocol in its current
Organic Letters | 2014
John Limanto; Eric R. Ashley; Jingjun Yin; Gregory L. Beutner; Brendan Grau; Amude Kassim; Mary M. Kim; Artis Klapars; Zhijian Liu; Hallena Strotman; Matthew D. Truppo
A novel synthesis of vernakalant is described. Using inexpensive and readily available reagents, the key transformations involve (1) an efficient zinc-amine-promoted etherification, (2) a highly stereoselective enzyme-catalyzed dynamic asymmetric transamination to set up the two contiguous chiral centers in the cyclohexane ring, and (3) a pyrrolidine ring formation via alkyl-B(OH)2-catalyzed amidation and subsequent imide reduction.
Organic Letters | 2014
John Chung; Yong-Li Zhong; Kevin M. Maloney; Robert A. Reamer; Jeffrey C. Moore; Hallena Strotman; Alexei Kalinin; Ronnie Feng; Neil A. Strotman; Bangping Xiang; Nobuyoshi Yasuda
An asymmetric synthesis of dual orexin receptor antagonist MK-6096 (1) is described. Key steps for the trans-2,5-disubstituted piperidinyl ether fragment include a biocatalytic transamination, a trans-selective Mukaiyama aldol, and a regioselective pyridyl SNAr process. The pyrimidyl benzoic acid was synthesized via a Negishi coupling and a nitrile hydrolysis. Coupling of the two fragments via a catalytic T3P-mediated amidation completed the synthesis. Unusual behaviors in the hydrolysis of pyrimidyl benzonitrile and the amide coupling of the pyrimidyl benzoic acid are also described.
Archive | 2016
John Chung; Benjamin Marcune; Hallena Strotman; Rositza I. Petrova; Jeffrey C. Moore; Peter G. Dormer
Related Article: John Y. L. Chung, Benjamin Marcune, Hallena R. Strotman, Rositza I. Petrova, Jeffrey C. Moore, Peter G. Dormer|2015|Org.Process Res.Dev.|19|1418|doi:10.1021/acs.oprd.5b00259
Organic Process Research & Development | 2015
John Chung; Benjamin Marcune; Hallena Strotman; Rositza I. Petrova; Jeffrey C. Moore; Peter G. Dormer
Archive | 2014
Matthew D. Truppo; Michel Journet; Hallena Strotman; Jonathan P. McMullen; Shane Grosser
Archive | 2011
John Limanto; Gregory L. Beutner; Jingjun Yin; Artis Klapars; Eric R. Ashley; Hallena Strotman; Matthew D. Truppo; Cheol K. Chung; Gregory Hughes; Zhijian Liu; Brendan Grau; Jacob Janey
Archive | 2014
Feng Xu; Zhuqing Liu; Richard Desmond; Jeonghan Park; Alexei Kalinin; Birgit Kosjek; Hallena Strotman; Hongmei Li; Johannah Moncecchi
Archive | 2014
Matthew D. Truppo; Hongmei Li; Johannah Moncecchi; Hallena Strotman
Archive | 2011
Fabien Louis Cabirol; Anupam Gohel; Steven J. Collier; Jack Liang; Marissa Mock; Emily Mundorff; Scott Novick; John Limanto; Derek Smith; Gregory L. Beutner; Artis Klapars; Eric R. Ashley; Hallena Strotman; Matthew D. Truppo; Gregory Hughes; Brendan Grau; Jacob Janey